sub:assertion {
  d:DB00755 v:identifier "DB00755" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB00755" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB00755> ;
    dv:drugbank-id "APRD00362" , "DB00755" , "NUTR00051" ;
    dv:x-ahfs <http://bio2rdf.org/ahfs:92:00.00> ;
    dv:x-atc <http://bio2rdf.org/atc:D10AD01> ;
    dv:x-cas <http://bio2rdf.org/cas:302-79-4> ;
    dv:x-chebi <http://bio2rdf.org/chebi:15367> ;
    dv:x-chemspider <http://bio2rdf.org/chemspider:5337> ;
    dv:x-dpd <http://bio2rdf.org/dpd:2243914> ;
    dv:x-kegg <http://bio2rdf.org/kegg:C00777> , <http://bio2rdf.org/kegg:D00094> ;
    dv:x-ndc <http://bio2rdf.org/ndc:0062-0187-02> ;
    dv:x-pharmgkb <http://bio2rdf.org/pharmgkb:PA451746> ;
    dv:x-pubchemcompound <http://bio2rdf.org/pubchem.compound:444795> ;
    dv:x-pubchemsubstance <http://bio2rdf.org/pubchem.substance:46504843> ;
    dv:x-wikipedia <http://bio2rdf.org/wikipedia:Tretinoin> ;
    dct:description "Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL)."@en ;
    dct:identifier "drugbank:DB00755" ;
    dct:title "Tretinoin"@en ;
    a dv:Drug ;
    rdfs:label "Tretinoin [drugbank:DB00755]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB00755> , <http://www.drugs.com/cdi/tretinoin.html> , <http://www.rxlist.com/cgi/generic/tretinoin.htm> .
}